Literature DB >> 8496675

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells.

S C Jameson1, F R Carbone, M J Bevan.   

Abstract

A previous report showed that the proliferative response of helper T cells to class II major histocompatibility complex (MHC)-restricted antigens can be inhibited by analogues of the antigen, which act as T cell receptor (TCR) antagonists. Here we define and analyze peptide variants that antagonize various functions of class I MHC-restricted cytotoxic T lymphocyte (CTL) clones. Of 64 variants at individual TCR contact sites of the Kb-restricted octamer peptide ovalbumin257-264 (OVAp), a very high proportion (40%) antagonized lysis by three OVAp-specific CTL clones. This effect was highly clone specific, since many antagonists for one T cell clone have differential effects on another. We show that this inhibition of CTL function is not a result of T cell-T cell interaction, precluding veto-like phenomena as a mechanism for antagonism. Moreover, we present evidence for direct interaction between the TCR and antagonist-MHC complexes. In further analysis of the T cell response, we found that serine esterase release and cytokine production are susceptible to TCR antagonism similarly to lysis. Ca2+ flux, an early event in signaling, is also inhibited by antagonists but may be more resistant to the antagonist effect than downstream responses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496675      PMCID: PMC2191028          DOI: 10.1084/jem.177.6.1541

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry.

Authors:  P S Rabinovitch; C H June; A Grossmann; J A Ledbetter
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

2.  Antigen recognition by T cells. Quantitative effects of augmentation by antibodies providing accessory interactions.

Authors:  K P Kane; M F Mescher
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

3.  An immunoregulatory function for the CD8 molecule.

Authors:  D R Kaplan; J E Hambor; M L Tykocinski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Introduction of soluble protein into the class I pathway of antigen processing and presentation.

Authors:  M W Moore; F R Carbone; M J Bevan
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

Review 5.  Veto cells.

Authors:  P J Fink; R P Shimonkevitz; M J Bevan
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

6.  T cell receptor beta-chain selection in human allograft rejection.

Authors:  M C Miceli; O J Finn
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

7.  A novel serine esterase expressed by cytotoxic T lymphocytes.

Authors:  M S Pasternack; H N Eisen
Journal:  Nature       Date:  1985 Apr 25-May 1       Impact factor: 49.962

8.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention.

Authors:  H Acha-Orbea; D J Mitchell; L Timmermann; D C Wraith; G S Tausch; M K Waldor; S S Zamvil; H O McDevitt; L Steinman
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

9.  Growth of factor-dependent hemopoietic precursor cell lines.

Authors:  T M Dexter; J Garland; D Scott; E Scolnick; D Metcalf
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

10.  Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.

Authors:  L Racioppi; F Ronchese; L A Matis; R N Germain
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  77 in total

1.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus.

Authors:  D Hudrisier; J Riond; J E Gairin
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis.

Authors:  Fang Zhao; Jennifer L Cannons; Mala Dutta; Gillian M Griffiths; Pamela L Schwartzberg
Journal:  Immunity       Date:  2012-06-07       Impact factor: 31.745

4.  Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c-I-E(k).

Authors:  Evan W Newell; Lauren K Ely; Andrew C Kruse; Philip A Reay; Stephanie N Rodriguez; Aaron E Lin; Michael S Kuhns; K Christopher Garcia; Mark M Davis
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

5.  T cell avidity and tumor immunity: problems and solutions.

Authors:  Arthur A Hurwitz; Steven M Cuss; Katherine E Stagliano; Ziqiang Zhu
Journal:  Cancer Microenviron       Date:  2013-12-20

6.  Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.

Authors:  Duane Moogk; Shi Zhong; Zhiya Yu; Ivan Liadi; William Rittase; Victoria Fang; Janna Dougherty; Arianne Perez-Garcia; Iman Osman; Cheng Zhu; Navin Varadarajan; Nicholas P Restifo; Alan B Frey; Michelle Krogsgaard
Journal:  J Immunol       Date:  2016-06-06       Impact factor: 5.422

7.  Variant antigenic peptide promotes cytotoxic T lymphocyte adhesion to target cells without cytotoxicity.

Authors:  D M Shotton; A Attaran
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 8.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.

Authors:  P J Fairchild; C J Thorpe; P J Travers; D C Wraith
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

9.  Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands.

Authors:  Y Ghendler; M K Teng; J H Liu; T Witte; J Liu; K S Kim; P Kern; H C Chang; J H Wang; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells.

Authors:  Simon H Apte; Adriana Baz; Penny Groves; Anne Kelso; Norbert Kienzle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.